1
|
Fairfield H, Falank C, Avery L and Reagan
MR: Multiple myeloma in the marrow: Pathogenesis and treatments.
Ann NY Acad Sci. 1364:32–51. 2016.PubMed/NCBI View Article : Google Scholar
|
2
|
Mena E, Choyke P, Tan E, Landgren O and
Kurdziel K: Molecular imaging in myeloma precursor disease. Semin
Hematol. 48:22–31. 2011.PubMed/NCBI View Article : Google Scholar
|
3
|
Caers J, Withofs N, Hillengass J, Simoni
P, Zamagni E, Hustinx R and Beguin Y: The role of positron emission
tomography-computed tomography and magnetic resonance imaging in
diagnosis and follow up of multiple myeloma. Haematologica.
99:629–637. 2014.PubMed/NCBI View Article : Google Scholar
|
4
|
Dutoit JC and Verstraete KL: MRI in
multiple myeloma: A pictorial review of diagnostic and
post-treatment findings. Insights Imaging. 7:553–569.
2016.PubMed/NCBI View Article : Google Scholar
|
5
|
Koutoulidis V, Papanikolaou N and
Moulopoulos LA: Functional and molecular MRI of the bone marrow in
multiple myeloma. Br J Radiol. 91(20170389)2018.PubMed/NCBI View Article : Google Scholar
|
6
|
Dietrich O, Biffar A, Baur-Melnyk A and
Reiser MF: Technical aspects of MR diffusion imaging of the body.
Eur J Radiol. 76:314–322. 2010.PubMed/NCBI View Article : Google Scholar
|
7
|
Messiou C, Giles S, Collins DJ, West S,
Davies FE, Morgan GJ and Desouza NM: Assessing response of myeloma
bone disease with diffusion-weighted MRI. Br J Radiol.
85:e1198–e1203. 2012.PubMed/NCBI View Article : Google Scholar
|
8
|
Messiou C and Kaiser M: Whole body
diffusion weighted MRI-a new view of myeloma. Br J Haematol.
171:29–37. 2015.PubMed/NCBI View Article : Google Scholar
|
9
|
Kwee TC, Takahara T, Ochiai R, Katahira K,
van Cauteren M, Imai Y, Nievelstein RA and Lujiten PR: Whole-body
diffusion-weighted magnetic resonance imaging. Eur J Radiol.
70:409–417. 2009.PubMed/NCBI View Article : Google Scholar
|
10
|
Dutoit JC and Verstraete KL: Whole-body
MRI, dynamic contrast-enhanced MRI, and diffusion-weighted imaging
for the staging of multiple myeloma. Skeletal Radiol. 46:733–750.
2017.PubMed/NCBI View Article : Google Scholar
|
11
|
Kumar S, Paiva B, Anderson KC, Durie B,
Landgren O, Moreau P, Munshi N, Lonial S, Bladé J, Mateos MV, et
al: International Myeloma Working Group consensus criteria for
response and minimal residual disease assessment in multiple
myeloma. Lancet Oncol. 17:e328–e346. 2016.PubMed/NCBI View Article : Google Scholar
|
12
|
He J, Fang H and Na Li X: Vertebral bone
marrow diffusivity in normal adults with varying bone densities at
3T diffusion-weighted imaging. Acta Radiol. 59:89–96.
2018.PubMed/NCBI View Article : Google Scholar
|
13
|
Griffith JF, Yeung DK, Ma HT, Leung JC,
Kwok TC and Leung PC: Bone marrow fat content in the elderly: A
reversal of sex difference seen in younger subjects. J Magn Reson
Imaging. 36:225–230. 2012.PubMed/NCBI View Article : Google Scholar
|
14
|
D'Anastasi M, Notohamiprodjo M, Schmidt
GP, Dürr HR, Reiser MF and Baur-Melnyk A: Tumor load in patients
with multiple myeloma: β2-microglobulin levels versus whole-body
MRI. AJR Am J Roentgenol. 203:854–862. 2014.PubMed/NCBI View Article : Google Scholar
|
15
|
Dimopoulos MA, Hillengass J, Usmani S,
Zamagni E, Lentzsch S, Davies FE, Raje N, Sezer O, Zweegman S, Shah
J, et al: Role of magnetic resonance imaging in the management of
patients with multiple myeloma: A consensus statement. J Clin
Oncol. 33:657–664. 2015.PubMed/NCBI View Article : Google Scholar
|
16
|
Cavo M, Terpos E, Nanni C, Moreau P,
Lentzsch S, Zweegman S, Hillengass J, Engelhardt M, Usmani SZ,
Vesole DH, et al: Role of 18F-FDG PET/CT in the
diagnosis and management of multiple myeloma and other plasma cell
disorders: A consensus statement by the International Myeloma
Working Group. Lancet Oncol. 18:e206–e217. 2017.PubMed/NCBI View Article : Google Scholar
|
17
|
Argyropoulos CP, Chen SS, Ng YH,
Roumelioti ME, Shaffi K, Singh PP and Tzamaloukas AH: Rediscovering
beta-2 Microglobulin as a biomarker across the spectrum of kidney
diseases. Front Med (Lausanne). 4(73)2017.PubMed/NCBI View Article : Google Scholar
|
18
|
Borsi E, Bucur A, Oncu CP, Oncu OP, Cerbu
B, Costachescu D, Ionita I, Luca CT and Ionita H: First line
therapy in multiple myeloma: Vad vs. bortezomib-dexamethasone. Rev
Chim. 70:1017–1022. 2019.
|
19
|
Pawlyn C and Davies FE: Toward
personalized treatment in multiple myeloma based on molecular
characteristics. Blood. 133:660–675. 2019.PubMed/NCBI View Article : Google Scholar
|
20
|
de Souza NM, Winfield JM, Waterton JC,
Weller A, Papoutsaki MV, Doran SJ, Collins DJ, Fournier L, Sullivan
D, Chenevert T, et al: Implementing diffusion-weighted MRI for body
imaging in prospective multicentre trials: Current considerations
and future perspectives. Eur Radiol. 28:1118–1131. 2018.PubMed/NCBI View Article : Google Scholar
|
21
|
Wu C, Huang J, Xu WB, Guan YJ, Ling HW, Mi
JQ and Yan H: Discriminating depth of response to therapy in
multiple myeloma using whole-body diffusion-weighted MRI with
apparent diffusion coefficient: Preliminary results from a
single-center study. Acad Radiol. 25:904–914. 2018.PubMed/NCBI View Article : Google Scholar
|
22
|
Mosavi F, Wassberg C, Selling J, Molin D
and Ahlstrom H: Whole-body diffusion-weighted MRI and 18F-FDG
PET/CT can discriminate between different lymphoma subtypes. Clin
Radiol. 70:1229–1236. 2015.PubMed/NCBI View Article : Google Scholar
|
23
|
Bonaffini PA, Ippolito D, Casiraghi A,
Besostri V, Franzesi CT and Sironi S: Apparent diffusion
coefficient maps integrated in whole-body MRI examination for the
evaluation of tumor response to chemotherapy in patients with
multiple myeloma. Acad Radiol. 22:1163–1171. 2015.PubMed/NCBI View Article : Google Scholar
|
24
|
Messiou C and Kaiser M: Whole-Body imaging
in multiple myeloma. Magn Reson Imaging Clin N Am. 26:509–525.
2018.PubMed/NCBI View Article : Google Scholar
|
25
|
Giles SL, Messiou C, Collins DJ, Morgan
VA, Simpkin CJ, West S, Davies FE, Morgan GJ and de Souza NM:
Whole-body diffusion-weighted MR imaging for assessment of
treatment response in myeloma. Radiology. 271:785–794.
2014.PubMed/NCBI View Article : Google Scholar
|
26
|
Koh DM and Thoeny HC (eds): MRI for
Disease Detection. In: Diffusion-weighted MR imaging, medical
radiology. Springer Berlin, Heidelberg, pp97-115, 2010.
|